Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01243112 · ClinicalTrials.gov registry record · Phase 4

Effectiveness Study of Different Local Anesthetic Mixtures

A Phase 4 study, sponsored by Scott and White Hospital & Clinic.

Completed
Registry status
Phase 4
Development phase
25
Enrollment target

NCT01243112 is a Phase 4 study that has completed, run by Scott and White Hospital & Clinic. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01243112, a Phase 4 study, has completed, sponsored by Scott and White Hospital & Clinic.

COMPLETED
Registry status
Phase 4
Development phase
25 participants
Enrollment target

Study Summary

Purpose and Background The purpose of this research study is to investigate the benefits of mixing lidocaine and bupivacaine for numbing the skin. Lidocaine and bupivacaine are two commonly used medications to numb the skin for minor procedures. Lidocaine has a faster onset. Bupivacaine has a longer duration. They are often combined with epinephrine to increase the length of action. These medications are used to control pain at the time of the operation and to decrease discomfort immediately afterward. Participating in the study involves injection of local anesthetic containing lidocaine, bupivacaine, and lidocaine and bupivacain with epinephrine at 4 sites on the forearm. Your participation will potentially improve the administration of these medications in persons undergoing a variety of procedures. You will be one of approximately 25 healthy volunteer subjects in this research study.

Interventions

  • DRUG 1% Lidocaine with Epinephrine (1:100,000)
  • DRUG 0.25% Bupivacaine with Epinephrine (1:200,000)
  • DRUG 0.5% Lidocaine, 0.125 Bupivacaine, and epi (1:150,000)
  • DRUG 1% Lidocaine, 0.5% Bupivacaine, and epinephrine (1:150,000)

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2010-05
Est. Completion 2010-09
Phase Phase 4

What the Registry Record Tells You About NCT01243112

The ClinicalTrials.gov registry entry for NCT01243112 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scott and White Hospital & Clinic, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which 1% Lidocaine with Epinephrine (1:100,000) is the first listed.

NCT01243112 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01243112 about?

NCT01243112 is a clinical study titled "Effectiveness Study of Different Local Anesthetic Mixtures". Purpose and Background The purpose of this research study is to investigate the benefits of mixing lidocaine and bupivacaine for numbing the skin. Lidocaine and bupivacaine are two commonly used medications to numb the skin for minor procedures. Lidocaine has a faster onset. Bupivacaine has a longer...

What is the current status of trial NCT01243112?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2010-05. Estimated completion is 2010-09.

What interventions are being tested in trial NCT01243112?

The interventions under investigation include: 1% Lidocaine with Epinephrine (1:100,000) (DRUG), 0.25% Bupivacaine with Epinephrine (1:200,000) (DRUG), 0.5% Lidocaine, 0.125 Bupivacaine, and epi (1:150,000) (DRUG), 1% Lidocaine, 0.5% Bupivacaine, and epinephrine (1:150,000) (DRUG).

Who is sponsoring clinical trial NCT01243112?

This trial is sponsored by Scott and White Hospital & Clinic, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.